Page last updated: 2024-08-23

epirubicin and Abnormalities, Cardiovascular

epirubicin has been researched along with Abnormalities, Cardiovascular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bins, AD; de Vries, EGE; Gietema, JA; Hooning, MJ; Jacobse, JN; Jager, A; Konings, IR; Kroep, JR; Linn, SC; Schaapveld, M; Schröder, CP; Seynaeve, CM; Smit, WM; Sonke, GS; Steenbruggen, TG; Steggink, LC; Tjan-Heijnen, VCG; van der Hoeven, JJM; van der Wall, E; van Leeuwen, FE; van Tinteren, H	1

Trials

1 trial(s) available for epirubicin and Abnormalities, Cardiovascular

Article	Year
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial. JAMA oncology, 2020, 04-01, Volume: 6, Issue:4 Topics: Adult; Axilla; Breast; Breast Neoplasms; Cardiovascular Abnormalities; Child; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged	2020

Article

Year

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.

JAMA oncology, 2020, 04-01, Volume: 6, Issue:4

Topics: Adult; Axilla; Breast; Breast Neoplasms; Cardiovascular Abnormalities; Child; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged

2020